Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
screening
MedTech
Quest Diagnostics taps MD Anderson for cancer risk blood test
Dubbed the multi-cancer stratification test, or MCaST, Quest said it may help identify people who could benefit from more frequent screenings.
Conor Hale
Jun 10, 2025 2:11pm
Exact Sciences plans 'transformative year' with new cancer tests
May 1, 2025 4:05pm
Study illustrates pros, cons of AI readings in 3D mammography
Apr 25, 2025 12:00pm
Exact Sciences kicks off launch of next-gen Cologuard Plus test
Mar 31, 2025 6:00am
JPM25: Guardant posts 31% sales gain as cancer blood tests grow
Jan 13, 2025 9:19am
USPSTF pushes HPV self-collection for cervical cancer screening
Dec 11, 2024 11:30am
